Summary

Persistence Market Research has recently released a comprehensive report on the global Patient Engagement Solution Market. This detailed analysis explores critical market dynamics, including drivers, trends, opportunities, and challenges, providing valuable insights into the market environment.

Key Insights:

• Patient Engagement Solution Market Size (2024E): USD 21.3 Bn
• Projected Market Value (2033F): USD 50.7 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 13.2%

Patient Engagement Solution Market - Report Scope:

Patient engagement solutions represent a notable advancement in healthcare, aiming to enhance patient involvement in their care. These solutions include various tools and technologies designed to improve communication between patients and healthcare providers, boost patient education, and elevate overall healthcare outcomes. The market comprises platforms such as patient portals, mobile health applications, and remote monitoring systems. The expansion of the patient engagement market is propelled by the growing focus on patient-centered care, advancements in digital health technologies, and the pursuit of improved healthcare results.

Market Growth Drivers:

Several factors are fueling the global patient engagement solution market, including the increasing demand for personalized and patient-centered healthcare services. Technological innovations in digital health, such as telemedicine, mobile health apps, and wearable devices, are enhancing patient engagement and driving market growth. The emphasis on chronic disease management and preventive care is also contributing to market expansion, as these solutions facilitate better monitoring and management of health conditions. Additionally, supportive government initiatives and healthcare reforms aimed at improving patient care and outcomes are further accelerating the adoption of patient engagement solutions.

Market Restraints:

Despite its growth potential, the patient engagement solution market encounters challenges related to data security, privacy concerns, and technological integration. Protecting patient data and ensuring compliance with regulations like HIPAA are critical for maintaining trust. The integration of patient engagement solutions with existing healthcare systems can be complex and costly, posing challenges for healthcare providers. Moreover, disparities in digital health literacy and access to technology among various patient populations may impede the widespread adoption of these solutions.

Market Opportunities:

The patient engagement solution market presents significant growth opportunities driven by technological advancements and evolving healthcare models. The integration of artificial intelligence (AI) and machine learning into patient engagement platforms can enhance personalized care and predictive analytics. Opportunities also exist in extending these solutions to underserved and rural areas with limited healthcare access. Strategic partnerships between technology providers, healthcare organizations, and payers can create new business models and drive market expansion. Furthermore, the increasing focus on value-based care and patient satisfaction opens avenues for developing innovative patient engagement solutions.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the global patient engagement solution market?
• Which types of patient engagement solutions are gaining traction in various regions?
• How are technological advancements influencing the competitive landscape of the patient engagement market?
• Who are the major players in the patient engagement solution market, and what strategies are they employing to stay relevant?
• What are the emerging trends and future prospects in the global patient engagement solution market?

Competitive Intelligence and Business Strategy:

Major players in the global patient engagement solution market, such as Cerner Corporation, Allscripts Healthcare Solutions, and Medisafe, are concentrating on innovation, product differentiation, and strategic partnerships to maintain a competitive edge. These companies invest in research and development to create advanced patient engagement tools, enhance interoperability with existing healthcare systems, and improve user experience. Collaborations with healthcare providers, technology firms, and regulatory bodies are crucial for driving market adoption and addressing emerging needs. Emphasizing data security, integration capabilities, and customer support is key to fostering market growth and ensuring the successful implementation of patient engagement solutions.

Key Companies Profiled:

• Allscripts Healthcare Solutions
• Mckesson Corporation
• Cerner Corporation
• Phytel Inc
• Medecision Inc
• Athenahealth Inc
• Novartis
• Roche Holding AG
• Bayer
• GlaxoSmithkline
• IQVIA

Key Segments of Patient Engagement Solution Market Industry Research

By Solution:

• Software
• Services

By Deployment:

• Cloud
• On Premise

By Application:

• Health Management
• Social Management
• Home Healthcare Management
• Financial Health Management

By End User:

• Patients
• Payers
• Healthcare Providers

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia Pacific
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Pricing Analysis
4.1. Pricing Analysis, By Solution
4.1.1. Subscription Pricing Model
4.1.2. Perpetual Licensing
4.2. Average Pricing Analysis Benchmark
5. Global Patient Engagement Solution Market Demand (in Value in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
5.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
5.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.2. Forecast Factors - Relevance & Impact
6.3. Value Chain
6.4. COVID-19 Crisis - Impact Assessment
6.4.1. Current Statistics
6.4.2. Short-Mid-Long Term Outlook
6.4.3. Likely Rebound
6.5. Market Dynamics
6.5.1. Drivers
6.5.2. Restraints
6.5.3. Opportunities
7. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Solution
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Bn) Analysis By Solution, 2019-2023
7.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Solution, 2024-2033
7.3.1. Software
7.3.1.1. Integrated Patient Engagement Software
7.3.1.2. Standalone Software
7.3.1.2.1. Scheduling Software
7.3.1.2.2. Billing Software
7.3.1.2.3. Secure Messaging Software
7.3.1.2.4. Others
7.3.2. Services
7.3.2.1. Implementation and Integration
7.3.2.2. Consulting
7.3.2.3. Support and Maintenance
7.4. Market Attractiveness Analysis By Solution
8. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Deployment
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Deployment, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Deployment, 2024-2033
8.3.1. Cloud
8.3.2. On-Premise
8.4. Market Attractiveness Analysis By Deployment
9. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
9.3.1. Health Management
9.3.2. Social Management
9.3.3. Home Healthcare Management
9.3.4. Financial Health Management
9.3.5. Others
9.4. Market Attractiveness Analysis By Application
10. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
10.3.1. Patients
10.3.2. Payers
10.3.3. Healthcare Providers
10.3.4. Others
10.4. Market Attractiveness Analysis By End User
11. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia Pacific
11.3.6. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
12.3.1. By Solution
12.3.2. By Deployment
12.3.3. By Application
12.3.4. By End User
12.3.5. By Country
12.3.5.1. U.S.
12.3.5.2. Canada
12.4. Market Attractiveness Analysis
12.4.1. By Solution
12.4.2. By Deployment
12.4.3. By Application
12.4.4. By End User
12.4.5. By Country
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
13. Latin America Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
13.3.1. By Solution
13.3.2. By Deployment
13.3.3. By Application
13.3.4. By End User
13.3.5. By Country
13.3.5.1. Brazil
13.3.5.2. Mexico
13.3.5.3. Rest of Latin America
13.4. Market Attractiveness Analysis
13.4.1. By Solution
13.4.2. By Deployment
13.4.3. By Application
13.4.4. By End User
13.4.5. By Country
14. Europe Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
14.3.1. By Solution
14.3.2. By Deployment
14.3.3. By Application
14.3.4. By End User
14.3.5. By Country
14.3.5.1. Germany
14.3.5.2. Italy
14.3.5.3. France
14.3.5.4. U.K.
14.3.5.5. Spain
14.3.5.6. BENELUX
14.3.5.7. Russia
14.3.5.8. Rest of Europe
14.4. Market Attractiveness Analysis
14.4.1. By Solution
14.4.2. By Deployment
14.4.3. By Application
14.4.4. By End User
14.4.5. By Country
15. South Asia & Pacific Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
15.3.1. By Solution
15.3.2. By Deployment
15.3.3. By Application
15.3.4. By End User
15.3.5. By Country
15.3.5.1. India
15.3.5.2. Indonesia
15.3.5.3. Malaysia
15.3.5.4. Singapore
15.3.5.5. Australia & New Zealand
15.3.5.6. Rest of South Asia and Pacific
15.4. Market Attractiveness Analysis
15.4.1. By Solution
15.4.2. By Deployment
15.4.3. By Application
15.4.4. By End User
15.4.5. By Country
16. East Asia Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
16.3.1. By Solution
16.3.2. By Deployment
16.3.3. By Application
16.3.4. By End User
16.3.5. By Country
16.3.5.1. China
16.3.5.2. Japan
16.3.5.3. South Korea
16.4. Market Attractiveness Analysis
16.4.1. By Solution
16.4.2. By Deployment
16.4.3. By Application
16.4.4. By End User
16.4.5. By Country
17. Middle East and Africa Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
17.3.1. By Solution
17.3.2. By Deployment
17.3.3. By Application
17.3.4. By End User
17.3.5. By Country
17.3.5.1. GCC Countries
17.3.5.2. Turkey
17.3.5.3. South Africa
17.3.5.4. Rest of Middle East and Africa
17.4. Market Attractiveness Analysis
17.4.1. By Solution
17.4.2. By Deployment
17.4.3. By Application
17.4.4. By End User
17.4.5. By Country
18. Key Countries Analysis- Patient Engagement Solution Market
18.1. U.S. Patient Engagement Solution Market Analysis
18.1.1. By Solution
18.1.2. By Deployment
18.1.3. By Application
18.1.4. By End User
18.2. Canada Patient Engagement Solution Market Analysis
18.2.1. By Solution
18.2.2. By Deployment
18.2.3. By Application
18.2.4. By End User
18.3. Mexico Patient Engagement Solution Market Analysis
18.3.1. By Solution
18.3.2. By Deployment
18.3.3. By Application
18.3.4. By End User
18.4. Brazil Patient Engagement Solution Market Analysis
18.4.1. By Solution
18.4.2. By Deployment
18.4.3. By Application
18.4.4. By End User
18.5. Germany Patient Engagement Solution Market Analysis
18.5.1. By Solution
18.5.2. By Deployment
18.5.3. By Application
18.5.4. By End User
18.6. Italy Patient Engagement Solution Market Analysis
18.6.1. By Solution
18.6.2. By Deployment
18.6.3. By Application
18.6.4. By End User
18.7. France Patient Engagement Solution Market Analysis
18.7.1. By Solution
18.7.2. By Deployment
18.7.3. By Application
18.7.4. By End User
18.8. U.K. Patient Engagement Solution Market Analysis
18.8.1. By Solution
18.8.2. By Deployment
18.8.3. By Application
18.8.4. By End User
18.9. Spain Patient Engagement Solution Market Analysis
18.9.1. By Solution
18.9.2. By Deployment
18.9.3. By Application
18.9.4. By End User
18.10. BENELUX Patient Engagement Solution Market Analysis
18.10.1. By Solution
18.10.2. By Deployment
18.10.3. By Application
18.10.4. By End User
18.11. Russia Patient Engagement Solution Market Analysis
18.11.1. By Solution
18.11.2. By Deployment
18.11.3. By Application
18.11.4. By End User
18.12. Rest of Europe Patient Engagement Solution Market Analysis
18.12.1. By Solution
18.12.2. By Deployment
18.12.3. By Application
18.12.4. By End User
18.13. China Patient Engagement Solution Market Analysis
18.13.1. By Solution
18.13.2. By Deployment
18.13.3. By Application
18.13.4. By End User
18.14. Japan Patient Engagement Solution Market Analysis
18.14.1. By Solution
18.14.2. By Deployment
18.14.3. By Application
18.14.4. By End User
18.15. South Korea Patient Engagement Solution Market Analysis
18.15.1. By Solution
18.15.2. By Deployment
18.15.3. By Application
18.15.4. By End User
18.16. India Patient Engagement Solution Market Analysis
18.16.1. By Solution
18.16.2. By Deployment
18.16.3. By Application
18.16.4. By End User
18.17. Malaysia Patient Engagement Solution Market Analysis
18.17.1. By Solution
18.17.2. By Deployment
18.17.3. By Application
18.17.4. By End User
18.18. Indonesia Patient Engagement Solution Market Analysis
18.18.1. By Solution
18.18.2. By Deployment
18.18.3. By Application
18.18.4. By End User
18.19. Singapore Patient Engagement Solution Market Analysis
18.19.1. By Solution
18.19.2. By Deployment
18.19.3. By Application
18.19.4. By End User
18.20. Australia and New Zealand Patient Engagement Solution Market Analysis
18.20.1. By Solution
18.20.2. By Deployment
18.20.3. By Application
18.20.4. By End User
18.21. GCC Countries Patient Engagement Solution Market Analysis
18.21.1. By Solution
18.21.2. By Deployment
18.21.3. By Application
18.21.4. By End User
18.22. Turkey Patient Engagement Solution Market Analysis
18.22.1. By Solution
18.22.2. By Deployment
18.22.3. By Application
18.22.4. By End User
18.23. South Africa Patient Engagement Solution Market Analysis
18.23.1. By Solution
18.23.2. By Deployment
18.23.3. By Application
18.23.4. By End User
18.24. Rest of Middle East and Africa Patient Engagement Solution Market Analysis
18.24.1. By Solution
18.24.2. By Deployment
18.24.3. By Application
18.24.4. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Allscripts Healthcare Solutions
20.3.1.1. Business Overview
20.3.1.2. Product Portfolio
20.3.1.3. Profitability by Market Segments (Business Segments/Region)
20.3.1.4. Key Strategy & Developments
20.3.2. Mckesson Corporation
20.3.2.1. Business Overview
20.3.2.2. Product Portfolio
20.3.2.3. Profitability by Market Segments (Business Segments/Region)
20.3.2.4. Key Strategy & Developments
20.3.3. Cerner Corporation
20.3.3.1. Business Overview
20.3.3.2. Product Portfolio
20.3.3.3. Profitability by Market Segments (Business Segments/Region)
20.3.3.4. Key Strategy & Developments
20.3.4. Phytel Inc
20.3.4.1. Business Overview
20.3.4.2. Product Portfolio
20.3.4.3. Profitability by Market Segments (Business Segments/Region)
20.3.4.4. Key Strategy & Developments
20.3.5. Medecision Inc
20.3.5.1. Business Overview
20.3.5.2. Product Portfolio
20.3.5.3. Profitability by Market Segments (Business Segments/Region)
20.3.5.4. Key Strategy & Developments
20.3.6. Athenahealth Inc
20.3.6.1. Business Overview
20.3.6.2. Product Portfolio
20.3.6.3. Profitability by Market Segments (Business Segments/Region)
20.3.6.4. Key Strategy & Developments
20.3.7. Novartis
20.3.7.1. Business Overview
20.3.7.2. Product Portfolio
20.3.7.3. Profitability by Market Segments (Business Segments/Region)
20.3.7.4. Key Strategy & Developments
20.3.8. Roche Holding AG
20.3.8.1. Business Overview
20.3.8.2. Product Portfolio
20.3.8.3. Profitability by Market Segments (Business Segments/Region)
20.3.8.4. Key Strategy & Developments
20.3.9. Bayer
20.3.9.1. Business Overview
20.3.9.2. Product Portfolio
20.3.9.3. Profitability by Market Segments (Business Segments/Region)
20.3.9.4. Key Strategy & Developments
20.3.10. GlaxoSmithkline
20.3.10.1. Business Overview
20.3.10.2. Product Portfolio
20.3.10.3. Profitability by Market Segments (Business Segments/Region)
20.3.10.4. Key Strategy & Developments
20.3.11. IQVIA
20.3.11.1. Business Overview
20.3.11.2. Product Portfolio
20.3.11.3. Profitability by Market Segments (Business Segments/Region)
20.3.11.4. Key Strategy & Developments
21. Assumptions and Acronyms Used
22. Research Methodology